Logo image of GRVO.PA

GRAINES VOLTZ SA (GRVO.PA) Stock Fundamental Analysis

EPA:GRVO - Euronext Paris - Matif - FR0000065971 - Common Stock - Currency: EUR

17.85  -0.1 (-0.56%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GRVO. GRVO was compared to 3 industry peers in the Distributors industry. While GRVO seems to be doing ok healthwise, there are quite some concerns on its profitability. GRVO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GRVO has reported negative net income.
In the past year GRVO had a positive cash flow from operations.
GRVO had positive earnings in 4 of the past 5 years.
In multiple years GRVO reported negative operating cash flow during the last 5 years.
GRVO.PA Yearly Net Income VS EBIT VS OCF VS FCFGRVO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.06%, GRVO is doing worse than 66.67% of the companies in the same industry.
With a decent Return On Equity value of -8.73%, GRVO is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a Return On Invested Capital value of 2.46%, GRVO is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for GRVO is below the industry average of 5.93%.
Industry RankSector Rank
ROA -4.06%
ROE -8.73%
ROIC 2.46%
ROA(3y)-0.06%
ROA(5y)2.68%
ROE(3y)-0.21%
ROE(5y)6.81%
ROIC(3y)2.52%
ROIC(5y)5.13%
GRVO.PA Yearly ROA, ROE, ROICGRVO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

GRVO's Operating Margin of 3.01% is on the low side compared to the rest of the industry. GRVO is outperformed by 66.67% of its industry peers.
GRVO's Operating Margin has declined in the last couple of years.
GRVO has a better Gross Margin (53.21%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of GRVO has grown nicely.
Industry RankSector Rank
OM 3.01%
PM (TTM) N/A
GM 53.21%
OM growth 3Y-34.24%
OM growth 5Y-16.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y9.9%
GRVO.PA Yearly Profit, Operating, Gross MarginsGRVO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GRVO is destroying value.
Compared to 1 year ago, GRVO has about the same amount of shares outstanding.
Compared to 5 years ago, GRVO has more shares outstanding
The debt/assets ratio for GRVO is higher compared to a year ago.
GRVO.PA Yearly Shares OutstandingGRVO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
GRVO.PA Yearly Total Debt VS Total AssetsGRVO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.30 indicates that GRVO is not a great score, but indicates only limited risk for bankruptcy at the moment.
GRVO has a better Altman-Z score (2.30) than 66.67% of its industry peers.
The Debt to FCF ratio of GRVO is 16.25, which is on the high side as it means it would take GRVO, 16.25 years of fcf income to pay off all of its debts.
GRVO has a Debt to FCF ratio of 16.25. This is in the better half of the industry: GRVO outperforms 66.67% of its industry peers.
GRVO has a Debt/Equity ratio of 0.76. This is a neutral value indicating GRVO is somewhat dependend on debt financing.
GRVO has a better Debt to Equity ratio (0.76) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 16.25
Altman-Z 2.3
ROIC/WACC0.61
WACC4.01%
GRVO.PA Yearly LT Debt VS Equity VS FCFGRVO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

GRVO has a Current Ratio of 1.94. This is a normal value and indicates that GRVO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GRVO (1.94) is better than 100.00% of its industry peers.
GRVO has a Quick Ratio of 1.01. This is a normal value and indicates that GRVO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GRVO (1.01) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.01
GRVO.PA Yearly Current Assets VS Current LiabilitesGRVO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The earnings per share for GRVO have decreased strongly by -974.48% in the last year.
Looking at the last year, GRVO shows a small growth in Revenue. The Revenue has grown by 1.03% in the last year.
GRVO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.09% yearly.
EPS 1Y (TTM)-974.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-497.53%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y3.2%
Revenue growth 5Y10.09%
Sales Q2Q%3.69%

3.2 Future

GRVO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -21.74% yearly.
The Revenue is expected to decrease by -6.24% on average over the next years.
EPS Next Y45.43%
EPS Next 2Y-21.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2Y-6.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRVO.PA Yearly Revenue VS EstimatesGRVO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
GRVO.PA Yearly EPS VS EstimatesGRVO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRVO. In the last year negative earnings were reported.
GRVO is valuated cheaply with a Price/Forward Earnings ratio of 3.44.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRVO indicates a rather cheap valuation: GRVO is cheaper than 100.00% of the companies listed in the same industry.
GRVO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 3.44
GRVO.PA Price Earnings VS Forward Price EarningsGRVO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

GRVO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GRVO is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GRVO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.29
EV/EBITDA 5.78
GRVO.PA Per share dataGRVO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRVO's earnings are expected to decrease with -21.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GRVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GRAINES VOLTZ SA

EPA:GRVO (5/30/2025, 7:00:00 PM)

17.85

-0.1 (-0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.42M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.44
P/S 0.2
P/FCF 7.29
P/OCF 2.84
P/B 0.4
P/tB 0.58
EV/EBITDA 5.78
EPS(TTM)-3.94
EYN/A
EPS(NY)5.19
Fwd EY29.09%
FCF(TTM)2.45
FCFY13.72%
OCF(TTM)6.3
OCFY35.27%
SpS90.81
BVpS45.13
TBVpS30.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -8.73%
ROCE 4.56%
ROIC 2.46%
ROICexc 2.64%
ROICexgc 3.27%
OM 3.01%
PM (TTM) N/A
GM 53.21%
FCFM 2.7%
ROA(3y)-0.06%
ROA(5y)2.68%
ROE(3y)-0.21%
ROE(5y)6.81%
ROIC(3y)2.52%
ROIC(5y)5.13%
ROICexc(3y)2.78%
ROICexc(5y)5.63%
ROICexgc(3y)3.51%
ROICexgc(5y)7.38%
ROCE(3y)4.46%
ROCE(5y)9.61%
ROICexcg growth 3Y-42.05%
ROICexcg growth 5Y-21.78%
ROICexc growth 3Y-40.13%
ROICexc growth 5Y-22.42%
OM growth 3Y-34.24%
OM growth 5Y-16.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y9.9%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 16.25
Debt/EBITDA 6.57
Cap/Depr 154.53%
Cap/Sales 4.24%
Interest Coverage 2.11
Cash Conversion 120.54%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.01
Altman-Z 2.3
F-Score5
WACC4.01%
ROIC/WACC0.61
Cap/Depr(3y)149.77%
Cap/Depr(5y)250.46%
Cap/Sales(3y)4.25%
Cap/Sales(5y)5.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-974.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-497.53%
EPS Next Y45.43%
EPS Next 2Y-21.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.03%
Revenue growth 3Y3.2%
Revenue growth 5Y10.09%
Sales Q2Q%3.69%
Revenue Next Year2.33%
Revenue Next 2Y-6.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y64.94%
EBIT growth 3Y-32.14%
EBIT growth 5Y-7.53%
EBIT Next Year111.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.24%
FCF growth 3Y-16.53%
FCF growth 5YN/A
OCF growth 1Y644.28%
OCF growth 3Y-1.76%
OCF growth 5Y40.2%